The Valley Desk

NCT01496274 · Interventional trial

A Safety and Efficacy Study of a Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Patients With Hemophilia B

Overall registry status Completed

Phase 2 · Phase 3

Conditions Hemophilia B

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov